David Johnston
No más puestos en curso
Perfil
El Dr. David Johnston es Vicepresidente Ejecutivo de Desarrollo Clínico Global en PPD, Inc. Anteriormente, el Dr. Johnston trabajó como Vicepresidente Senior en Laboratory Corp. of America Holdings. También formó parte de la junta directiva de Locus Biosciences, Inc. Se licenció en la Universidad de Carolina del Norte en Greensboro y se doctoró en la Facultad de Medicina de la UNC.
Antiguos cargos conocidos de David Johnston.
Empresas | Cargo | Fin |
---|---|---|
PPD, INC. | President | 01/10/2023 |
THERMO FISHER SCIENTIFIC | Chief Tech/Sci/R&D Officer | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Director/Board Member | - |
LABORATORY CORPORATION OF AMERICA HOLDINGS | Corporate Officer/Principal | - |
Formación de David Johnston.
The University of North Carolina at Greensboro | Undergraduate Degree |
UNC School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
THERMO FISHER SCIENTIFIC | Health Technology |
Empresas privadas | 2 |
---|---|
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
PPD, Inc.
PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
- Bolsa de valores
- Insiders
- David Johnston